Biological treatments in Behçet's disease: beyond anti-TNF therapy.
about
Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of DiseaseMucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future PerspectivesInterleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesAdalimumab effectiveness in Behçet's disease: short and long-term data from a multicenter retrospective observational study.Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.Expression of MicroRNAs in the Eyes of Lewis Rats with Experimental Autoimmune Anterior Uveitis.Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.Update on the Medical Management of Gastrointestinal Behçet's Disease.Ocular Involvement in Systemic Autoimmune Diseases.Emerging drugs for psoriatic arthritis.Management of severe complications in Behçet's disease with TNF inhibitors.The potential of genetically guided treatment in Behçet's disease.Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet's disease susceptibility.Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.Mean platelet volume as a marker for differentiating disease flare from infection in Behçet's disease.Neurological complications of Behçet's syndrome.Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study.Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study.Intestinal and neurological involvement in Behcet disease: a clinical case.Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence.A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry.Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis.Efficacy and safety of ustekinumab in adolescents.Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome.Intracardiac thrombosis in Behçet's Disease successfully treated with immunosuppressive agents: A case of vascular pathergy phenomenon.Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimensInterleukin-1 blockade in neuro-Behçet's disease: a case-based reflectionDevelopment of de novo major involvement during follow-up in Behçet’s syndromeThe Broad-Ranging Panorama of Systemic Autoinflammatory Disorders with Specific Focus on Acute Painful Symptoms and Hematologic Manifestations in Children
P2860
Q26781862-51DDF4B4-5C6E-4929-A7AF-DAEEA90EB815Q26799767-154E745C-D55E-4700-AEBA-DF77F33BBA95Q35133812-D861E52A-3D8F-4645-9BB9-A6054D142472Q36146582-180AC4BB-B98C-4A85-B8F3-6430F19CE258Q36207025-D7AC2B2A-4C69-4472-B026-76A674886C1BQ36374652-C962597E-7FCD-4461-8BE9-C33C8AFAD8CFQ36484399-6EC61D4B-539A-4B6B-8C1A-617A4B427D16Q37624811-5850E957-F279-4082-BA5D-005CECF84775Q38614543-EDD7507E-E861-446D-B04F-773C0F10F144Q38710642-319E8F29-02DA-4E56-BF36-13385F720481Q38786414-F710442C-F793-4CCB-B628-4921FCB47149Q38848128-699826D5-896F-469A-9B8E-42B2BD042DC1Q38976440-97271476-A12A-480F-B199-56DD65A0A36BQ39096171-1B785A11-D199-41D1-935C-2466348E4BF2Q39154222-4B19D89A-DACA-4D82-AFFA-D6AE4EA1AB3CQ39173608-749156C1-9A06-4F9E-B6BF-C881A33283F0Q40630984-6DF00EF5-7DFD-425C-A930-C1DC826512E0Q40756639-648FD99F-4D08-45BE-8DFA-9BC40B11F2B4Q42292558-A3E17F6F-B90D-49F8-8C1F-1716B7CFF5D1Q47114261-C7EE23DC-74AC-447C-96D4-6FD15CD5C293Q47161164-76EF2DC9-276B-406C-A639-E381F61D0FD3Q48189498-46181CFC-5D3A-46B5-8AB9-6F40830FCC5BQ49500789-D10B3807-87D8-4FFD-AA66-5BF874F460C7Q52148791-0BC1DCC0-6E61-47B8-A684-9B53DBDF48B1Q55315389-1E16D3C0-7A1E-40E1-9D6E-4A6DC12EB7F6Q58326000-1BE88B36-10BB-4EC2-9FDD-B8CD52D90285Q58326027-E51074A3-923D-4F4C-8A37-12891B4E0FFDQ58326028-2A130035-1F08-40E4-8AA3-CF886117F6D6Q58701100-1F2DC08C-26CE-4CD2-8400-E4C8B261A782
P2860
Biological treatments in Behçet's disease: beyond anti-TNF therapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Biological treatments in Behçet's disease: beyond anti-TNF therapy.
@ast
Biological treatments in Behçet's disease: beyond anti-TNF therapy.
@en
type
label
Biological treatments in Behçet's disease: beyond anti-TNF therapy.
@ast
Biological treatments in Behçet's disease: beyond anti-TNF therapy.
@en
prefLabel
Biological treatments in Behçet's disease: beyond anti-TNF therapy.
@ast
Biological treatments in Behçet's disease: beyond anti-TNF therapy.
@en
P2093
P2860
P50
P921
P356
P1476
Biological treatments in Behçet's disease: beyond anti-TNF therapy
@en
P2093
Bruno Frediani
Carmela G L Raffaele
Giusyda Tarantino
Laura Nieves-Martín
Mariangela Atteno
Mauro Galeazzi
Paolo Caso
Rolando Cimaz
Vittoria Bascherini
P2860
P304
P356
10.1155/2014/107421
P50
P5008
P577
2014-06-30T00:00:00Z